Letter to the editor regarding “The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature” by Humaid et al

Saved in:
Bibliographic Details
Published inThe spine journal Vol. 24; no. 7; pp. 1335 - 1337
Main Authors Niu, Hua-Qing, Zheng, Bo-Yv, Wu, Hai-Lin, Zheng, Bo-Wen
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.07.2024
Subjects
Bone Density Conservation Agents - adverse effects
Bone Density Conservation Agents - therapeutic use
Denosumab - therapeutic use
Giant Cell Tumor of Bone - drug therapy
Humans
Neoadjuvant Therapy
Spinal Neoplasms - drug therapy
Online AccessGet full text

Cover

More Information
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ISSN:1529-9430
1878-1632
1878-1632
DOI:10.1016/j.spinee.2024.03.020